Madrigal Pharmaceuticals (MDGL) PT Lowered to $200 at Oppenheimer; 'Temporarily in the Penalty Box'
Tweet Send to a Friend
Oppenheimer analyst Jay Olson lowered the price target on Madrigal Pharmaceuticals (NASDAQ: MDGL) to $200.00 (from $300.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
